Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)

单核细胞趋化蛋白-1（MCP-1；CCL2）的全身抑制

• 批准号: 8082762
• 负责人: ROBERT LOBERG
• 金额: $ 28.08万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8082762
• 关键词: Antibodies; Beds; Blood Circulation; Bone Marrow; Breast; CCL2 gene; Cancer Biology; Carcinoma; Cells; Cervix Uteri; Chemotactic Factors; Collaborations; Data; Development; Effectiveness; Epithelial Cells; Exhibits; Growth; Histocompatibility Testing; Human; Immune; In Vitro; Infiltration; Letters; Link; Lymphocyte; Malignant Neoplasms; Malignant neoplasm of prostate; Mediating; Modeling; Monocyte Chemoattractant Protein-1; Mus; Neoadjuvant Therapy; Neoplasm Metastasis; Out-Migrations; PC3 cell line; Pancreas; Pancreatic carcinoma; Patients; Pilot Projects; Population; Prostate; Prostatectomy; Prostatic Neoplasms; Proteins; Recruitment Activity; Reproduction spores; Role; Site; Source; Testing; Tissues; Up-Regulation; Work; androgen independent prostate cancer; base; cancer cell; cell growth; design; effective therapy; efficacy trial; human monoclonal antibodies; in vivo; interest; macrophage; men; migration; monocyte; monocyte chemoattractant protein 1 receptor; neoplastic; neoplastic cell; neutralizing antibody; novel; peripheral blood; phase 2 study; programs; research study; response; tumor; tumor growth; tumorigenesis